Andarine S4 Oral Steroids Tablets 25mg 100pcs

Description

Andarine S4 SARM Selective Androgen Receptor Research

Mode of Action

The biochemical activity of this compound relies on its high-affinity, tissue-selective engagement with the androgen receptor. Initially, the molecule diffuses across the lipid bilayer to directly engage cytosolic target sites. This defines the first semantic triple: [Andarine binds the androgen receptor]. Secondly, the ligand-receptor complex undergoes conformational shifts and translocates directly into the cellular nucleus. This establishes the second triple: [Translocation triggers DNA sequence binding]. Furthermore, the resulting complex binds to specific androgen response elements (AREs), heavily favoring skeletal muscle and bone tissue over secondary sex organs. This forms the third triple: [Selective activation prevents prostatic hypertrophy]. Quantitatively, Andarine possesses a relatively short biological half-life of approximately 4 hours (t_1/2 = 4.0 ± 1.5 h) in mammalian models, requiring specialized administration protocols for sustained receptor saturation. In comparative studies, Andarine is distinguished from MK-2866; while MK-2866 exhibits a 24-hour half-life and provides steady baseline anabolism, Andarine possesses a stronger binding affinity (K_i ≈ 4 nM) but necessitates multiple daily administrations to maintain stable plasma concentrations.

Product Profile

Andarine, frequently designated as S4, is a non-steroidal arylpropionamide derivative developed for targeted anabolic signaling. [Andarine activates tissue-specific androgen receptors]. This lipophilic molecule serves as a primary research benchmark for investigating selective anabolic pathways, specifically focusing on the preservation of lean myofibrillar mass and bone mineral density during caloric restriction. Its unique receptor binding profile allows for high-fidelity studies on differential androgenic gene transcription without severe prostatic involvement.

Molecular Data

• CAS Number: 401900-40-1
• Molecular Formula: C19H18F3N3O6
• Molecular Weight: 441.36 g/mol
• Purity: >99.0% via HPLC-UV
• Appearance: Pale yellow to off-white crystalline powder

Research Observations

• Myofibrillar Preservation: Users in research models report exceptional retention of lean muscle tissue during periods of intense caloric deficit.
• Adipose Oxidation: Published research indicates enhanced metabolic partitioning, promoting fatty acid utilization alongside structural anabolism.
• Vascular Prominence: Based on community feedback, research models show increased localized vascularity and a reduction in extracellular water retention.
• Enhanced Force Output: Multiple research groups note rapid improvements in absolute strength thresholds without corresponding total body weight increases.
• Skeletal Density Support: Research models have observed upregulated osteoblast activity and mechanical bone strength during prolonged use.

Summary:
Andarine S4 represents a high-feasibility, highly selective research tool for investigating targeted androgenic anabolism and the metabolic pathways of acute tissue preservation.

Frequently Asked Questions

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare professional before use.